Highlight: microfluidic devices for cancer metastasis studies
Tóm tắt
Whilst cancer is the single most researched disease by number of clinical trials, it remains a leading cause of death in middle- to high-income countries, with metastasis as the prime factor in cancer-associated mortality. The complex, multistep process of metastasis, in which cancer cells disseminate from the primary tumour and home to distant sites, is modulated by an extensive set of factors such as matrix properties, cancer cell plasticity, intercellular communication and oxygen tension. However, traditional treatment approaches have been focussed on the removal of the primary and secondary lesions, rather than interference with the metastatic cascade. Microfluidic platforms enable the deconvolution of the processes involved in metastasis by recapitulating key aspects of the tumour microenvironment in a controlled and reproducible fashion. Herein, we review recent developments in microfluidics for metastasis research and explain how these devices offer exceptional potential towards gaining a deeper understanding of this key aspect of malignancy.
Tài liệu tham khảo
Steeg PS. Tumor metastasis: mechanistic insights and clinical challenges. Nat Med. 2006;12(8):895–904. https://doi.org/10.1038/nm1469.
Fares J, Fares MY, Khachfe HH, Salhab HA, Fares Y. Molecular principles of metastasis: a hallmark of cancer revisited. Signal Transduct Target Ther. 2020;5(1):28. https://doi.org/10.1038/s41392-020-0134-x.
Glatzer M, Panje CM, Sirén C, Cihoric N, Putora PM. Decision Making Criteria in Oncology. Oncology. 2020;98(Suppl. 6):370–8. https://doi.org/10.1159/000492272.
Pearce OMT, et al. Deconstruction of a metastatic tumor microenvironment reveals a common matrix response in human cancers. Cancer Discov. 2018;8(3):304–19. https://doi.org/10.1158/2159-8290.CD-17-0284.
Hurst J, et al. A novel model of a metastatic human breast tumour xenograft line. Br J Cancer. 1993;68(2):274–6. https://doi.org/10.1038/bjc.1993.327.
Stewart TA, Pattengale PK, Leder P. Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes. Cell. 1984;38(3):627–37. https://doi.org/10.1016/0092-8674(84)90257-5.
Brinster RL, Chen HY, Messing A, van Dyke T, Levine AJ, Palmiter RD. Transgenic mice harboring SV40 t-antigen genes develop characteristic brain tumors. Cell. 1984;37(2):367–79. https://doi.org/10.1016/0092-8674(84)90367-2.
Sinn E, Muller W, Pattengale P, Tepler I, Wallace R, Leder P. Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: synergistic action of oncogenes in vivo. Cell. 1987;49(4):465–75. https://doi.org/10.1016/0092-8674(87)90449-1.
Hill W, Caswell DR, Swanton C. Capturing cancer evolution using genetically engineered mouse models (GEMMs). Trends Cell Biol. 2021;31(12):1007–18. https://doi.org/10.1016/j.tcb.2021.07.003.
McFadden DG et al. Mutational landscape of EGFR- , MYC- , and Kras- driven genetically engineered mouse models of lung adenocarcinoma. Proc Natl Acad Sci. 2016;113(42). https://doi.org/10.1073/pnas.1613601113
Ogasawara M, Matsubara T, Suzuki H. Screening of natural compounds for inhibitory activity on colon cancer cell migration. Biol Pharm Bull. 2001;24(6):720–3. https://doi.org/10.1248/bpb.24.720.
Hulkower KI, Herber RL. Cell migration and invasion assays as tools for drug discovery. Pharmaceutics. 2011;3(1):107–24. https://doi.org/10.3390/pharmaceutics3010107.
Zaman MH, et al. Migration of tumor cells in 3D matrices is governed by matrix stiffness along with cell-matrix adhesion and proteolysis. Proc Natl Acad Sci. 2006;103(29):10889–94. https://doi.org/10.1073/pnas.0604460103.
Pathak A, Kumar S. Independent regulation of tumor cell migration by matrix stiffness and confinement. Proc Natl Acad Sci. 2012;109(26):10334–9. https://doi.org/10.1073/pnas.1118073109.
Tozluoğlu M, Tournier AL, Jenkins RP, Hooper S, Bates PA, Sahai E. Matrix geometry determines optimal cancer cell migration strategy and modulates response to interventions. Nat Cell Biol. 2013;15(7):751–62. https://doi.org/10.1038/ncb2775.
Wisdom KM, et al. Matrix mechanical plasticity regulates cancer cell migration through confining microenvironments. Nat Commun. 2018;9(1):4144. https://doi.org/10.1038/s41467-018-06641-z.
Viola K, et al. Bay11-7082 inhibits the disintegration of the lymphendothelial barrier triggered by MCF-7 breast cancer spheroids; the role of ICAM-1 and adhesion. Br J Cancer. 2013;108(3):564–9. https://doi.org/10.1038/bjc.2012.485.
Velasco V, Shariati SA, Esfandyarpour R. Microtechnology-based methods for organoid models. Microsyst Nanoeng. 2020;6(1):76. https://doi.org/10.1038/s41378-020-00185-3.
Huh D, Matthews BD, Mammoto A, Montoya-Zavala M, Yuan Hsin H, Ingber DE. Reconstituting organ-level lung functions on a chip. Science, 2010. https://doi.org/10.1126/science.1188302
de Jong J, Lammertink RGH, Wessling M. Membranes and microfluidics: a review. Lab Chip. 2006;6(9):1125. https://doi.org/10.1039/b603275c.
Jang K-J, Suh K-Y. A multi-layer microfluidic device for efficient culture and analysis of renal tubular cells. Lab Chip. 2010;10(1):36–42. https://doi.org/10.1039/B907515A.
Choi NW, Cabodi M, Held B, Gleghorn JP, Bonassar LJ, Stroock AD. Microfluidic scaffolds for tissue engineering. Nat Mater. 2007;6(11):908–15. https://doi.org/10.1038/nmat2022.
Stucki AO, et al. A lung-on-a-chip array with an integrated bio-inspired respiration mechanism. Lab Chip. 2015. https://doi.org/10.1039/c4lc01252f.
Liu Y, et al. Human in vitro vascularized micro-organ and micro-tumor models are reproducible organ-on-a-chip platforms for studies of anticancer drugs. Toxicology. 2020. https://doi.org/10.1016/j.tox.2020.152601.
Zervantonakis IK, Hughes-Alford SK, Charest JL, Condeelis JS, Gertler FB, Kamm RD. Three-dimensional microfluidic model for tumor cell intravasation and endothelial barrier function. Proc Natl Acad Sci U S A. 2012. https://doi.org/10.1073/pnas.1210182109.
Jeon JS, et al. Human 3D vascularized organotypic microfluidic assays to study breast cancer cell extravasation. Proc Natl Acad Sci U S A. 2015. https://doi.org/10.1073/pnas.1417115112.
Aleman J, Skardal A. A multi-site metastasis-on-a-chip microphysiological system for assessing metastatic preference of cancer cells. Biotechnol Bioeng. 2019;116(4):936–44. https://doi.org/10.1002/bit.26871.
Crippa M, et al. A microphysiological early metastatic niche on a chip reveals how heterotypic cell interactions and inhibition of integrin subunit β 3 impact breast cancer cell extravasation. Lab Chip. 2021;21(6):1061–72. https://doi.org/10.1039/D0LC01011A.
Lee JH, Kim SK, Khawar IA, Jeong SY, Chung S, Kuh HJ. Microfluidic co-culture of pancreatic tumor spheroids with stellate cells as a novel 3D model for investigation of stroma-mediated cell motility and drug resistance. J Exp Clin Cancer Res. 2018. https://doi.org/10.1186/s13046-017-0654-6.
Nashimoto Y, et al. Integrating perfusable vascular networks with a three-dimensional tissue in a microfluidic device. Integr Biol (United Kingdom). 2017. https://doi.org/10.1039/c7ib00024c.
Azadi S, Tafazzoli Shadpour M, Warkiani ME. Characterizing the effect of substrate stiffness on the extravasation potential of breast cancer cells using a 3D microfluidic model. Biotechnol. Bioeng. 2021. https://doi.org/10.1002/bit.27612
Rizvi I, et al. Flow induces epithelial-mesenchymal transition, cellular heterogeneity and biomarker modulation in 3D ovarian cancer nodules. Proc Natl Acad Sci U S A. 2013. https://doi.org/10.1073/pnas.1216989110.
Hajal C, Ibrahim L, Serrano JC, Offeddu GS, Kamm RD. The effects of luminal and trans-endothelial fluid flows on the extravasation and tissue invasion of tumor cells in a 3D in vitro microvascular platform. Biomaterials. 2021;265: 120470. https://doi.org/10.1016/j.biomaterials.2020.120470.
Tang Y, Soroush F, Sheffield JB, Wang B, Prabhakarpandian B, Kiani MF. A biomimetic microfluidic tumor microenvironment platform mimicking the EPR effect for rapid screening of drug delivery systems. Sci Rep. 2017;7(1):9359. https://doi.org/10.1038/s41598-017-09815-9.
Shirure VS, et al. Tumor-on-a-chip platform to investigate progression and drug sensitivity in cell lines and patient-derived organoids. Lab Chip. 2018;18(23):3687–702. https://doi.org/10.1039/C8LC00596F.
Sobrino A, et al. 3D microtumors in vitro supported by perfused vascular networks. Sci Rep. 2016;6(1):31589. https://doi.org/10.1038/srep31589.
Mi S, et al. Microfluidic co-culture system for cancer migratory analysis and anti-metastatic drugs screening. Sci Rep. 2016;6(1):35544. https://doi.org/10.1038/srep35544.
Chi C, et al. High-throughput tumor-on-a-chip platform to study tumor–stroma interactions and drug pharmacokinetics. Adv Healthc Mater. 2020;9(21):2000880. https://doi.org/10.1002/adhm.202000880.
Albanese A, Lam AK, Sykes EA, Rocheleau JV, Chan WCW. Tumour-on-a-chip provides an optical window into nanoparticle tissue transport. Nat Commun. 2013;4(1):2718. https://doi.org/10.1038/ncomms3718.
Kwak B, Ozcelikkale A, Shin CS, Park K, Han B. Simulation of complex transport of nanoparticles around a tumor using tumor-microenvironment-on-chip. J Control Release. 2014;194:157–67. https://doi.org/10.1016/j.jconrel.2014.08.027.